Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Pulmonary Alveolar Proteinosis (PAP) Market: Industry Analysis & Outlook 2017-2025 - Research and Markets

Research and Markets
Posted on: 19 Dec 17

The "Global Pulmonary Alveolar Proteinosis (PAP) Market: Industry Analysis & Outlook (2017-2025)" report has been added to Research and Markets' offering.

Global Pulmonary Alveolar Proteinosis (PAP) Market: Industry Analysis & Outlook (2017-2025) analyzes the development of this market, with focus on the US, Europe, and Japan region. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. A key upcoming player in the market i.e. Savara Inc. is being profiled along with its key financials and strategies for growth. The report contains a comprehensive analysis of the global PAP market along with the study of the regional markets.

Treatment of PAP depends on the form of PAP and age of a patient with PAP and severity of the disease. WLL is a standard treatment for PAP and the only treatment which has shown improved symptoms and oxygenation in patients. Another treatment of PAP includes using recombinant granulocyte colony stimulating factor (GM-CSF) which is given by nose or with a subcutaneous injection which is not approved yet.

The global PAP market is expected to show significant growth after the introduction of the molgradex drug in 2020. The growth of market will mainly be driven by huge unmet demand, increasing male population, rising middle-aged population and increasing health expenditure. However, the growth of the market will be hindered by the absence of effective diagnostics and costly drugs.

Key Topics Covered:

1. Market Overview

2. Global PAP Market

3. Regional Market Analysis

4. Market Dynamics

5. Competitive Landscape

6. Company Profiles

  • Savara Inc.

For more information about this report visit https://www.researchandmarkets.com/research/qmnwqf/global_pulmonary?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20171219006082/en/

Business Wire
www.businesswire.com

Last updated on: 19/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.